Related Experiment Video

Updated: Aug 31, 2026

Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats
08:55

Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats

Published on: April 15, 2016

[Adenovirus p16(INK4A) gene therapy for laryngeal squamous cell carcinoma]

Shi-xi Liu1, Si-quan Tang, Chuan-yu Liang

  • 1Department of Otorhinolaryngology, West China Hospital, Sichuan University, Chengdu 610041, China. liusx@mcwcums.com

Zhonghua Er Bi Yan Hou Ke Za Zhi
|June 5, 2003
PubMed
Abstract

Insights

Gene transfer of p16INK4A using adenovirus (Ad-p16) effectively inhibited laryngeal cancer growth in vitro and in vivo. This study supports Ad-p16 as a potential therapy for head and neck cancers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Therapy

Context:

  • Laryngeal squamous cell carcinoma (LSCC) is a significant global health concern.
  • Current treatment options for LSCC have limitations.
  • Gene therapy offers a promising avenue for cancer treatment.

Purpose:

  • To evaluate the antitumor efficacy of p16INK4A gene transfer in LSCC.
  • To assess the safety and effectiveness of Ad-p16 in preclinical models.

Summary:

  • A replication-defective adenovirus vector (Ad-p16) was engineered to deliver the p16INK4A gene into LSCC cells.
  • Western Blotting confirmed high p16INK4A protein expression post-infection.
  • In vitro and in vivo studies demonstrated significant inhibition of LSCC cell proliferation and tumor growth in nude mice treated with Ad-p16.

Impact:

  • Ad-p16 exhibits significant antitumor effects against human LSCC.
  • These findings support the potential clinical application of Ad-p16 for treating head and neck cancers.
  • This research contributes to the development of novel gene-based cancer therapies.

More Related Videos

Adenoviral Gene Therapy for Diabetic Keratopathy: Effects on Wound Healing and Stem Cell Marker Expression in Human Organ-cultured Corneas and Limbal Epithelial Cells11:13

Adenoviral Gene Therapy for Diabetic Keratopathy: Effects on Wound Healing and Stem Cell Marker Expression in Human Organ-cultured Corneas and Limbal Epithelial Cells

Published on: April 7, 2016

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Related Concept Videos

Gene Therapy01:22

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.